Section Arrow
Quote
TEVA.NYSE
- Teva Pharmaceutical Industries Limited
Quotes are at least 15-min delayed:2026/02/10 05:58 EST
Pre Market
Last
 34.13
-0.34 (-0.99%)
Bid
34.15
Ask
34.33
High 34.17 
Low 34.06 
Volume 6.24K 
Regular Hours (Closed)
Last
 34.47
-0.22 (-0.63%)
Day High 
34.63 
Prev. Close
34.69 
1-M High
37.345 
Volume 
7.55M 
Bid
34.15
Ask
34.33
Day Low
34.27 
Open
34.57 
1-M Low
30.7 
Market Cap 
39.89B 
Currency 美元 
P/E 28.31 
%Yield 0.25 
10-SMA 34.13 
20-SMA 33.08 
50-SMA 31.1 
52-W High 37.345 
52-W Low 12.465 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
1.21/3.10
Enterprise Value
55.16B
Balance Sheet
Book Value Per Share
6.88
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
17.26B
Operating Revenue Per Share
13.06
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health19.33-3.69-16.03%36.28PE
Pre Market 18.81 -0.52 -2.69%
VTRSViatris15.56+0.98+6.72%227.2PE
Pre Market 15.59 +0.03 +0.19%
BFRIBiofrontera0.8103-0.0107-1.30%0.74PE
Pre Market 0.7424 -0.0679 -8.38%
CGCCanopy Growth Corp1.09-0.01-0.91%-- 
Pre Market 1.11 +0.02 +1.83%
HLNHaleon plc10.88-0.1-0.91%23.79PE
Pre Market 10.85 -0.03 -0.28%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.